2020 Q1 Form 10-Q Financial Statement

#000162828020006544 Filed on May 06, 2020

View on sec.gov

Income Statement

Concept 2020 Q1 2019 Q1
Revenue $84.30K $364.2K
YoY Change -76.85% -34.97%
Cost Of Revenue $1.748M $1.398M
YoY Change 25.07% -18.27%
Gross Profit -$1.664M -$1.033M
YoY Change 60.99% -10.14%
Gross Profit Margin -1973.52% -283.77%
Selling, General & Admin $5.566M $2.091M
YoY Change 166.19% -12.88%
% of Gross Profit
Research & Development $1.902M $1.362M
YoY Change 39.64% -41.78%
% of Gross Profit
Depreciation & Amortization $171.8K $96.69K
YoY Change 77.65% 93.37%
% of Gross Profit
Operating Expenses $7.468M $3.453M
YoY Change 116.27% -27.15%
Operating Profit -$8.267M -$4.487M
YoY Change 84.26% -23.83%
Interest Expense $13.02M $1.778M
YoY Change 632.46% -435.39%
% of Operating Profit
Other Income/Expense, Net $860.0K
YoY Change
Pretax Income $4.757M -$6.264M
YoY Change -175.93% -2.43%
Income Tax $0.00 $0.00
% Of Pretax Income 0.0%
Net Earnings $4.757M -$6.264M
YoY Change -175.93% -2.43%
Net Earnings / Revenue 5642.58% -1720.07%
Basic Earnings Per Share $0.07 -$0.11
Diluted Earnings Per Share $0.06 -$0.11
COMMON SHARES
Basic Shares Outstanding 68.47M shares 55.26M shares
Diluted Shares Outstanding 83.77M shares 55.26M shares

Balance Sheet

Concept 2020 Q1 2019 Q1
SHORT-TERM ASSETS
Cash & Short-Term Investments $16.80M $2.800M
YoY Change 500.0% 250.0%
Cash & Equivalents $16.82M $2.848M
Short-Term Investments
Other Short-Term Assets $4.800M $2.000M
YoY Change 140.0% 900.0%
Inventory $2.631M $2.500M
Prepaid Expenses
Receivables $48.83K $400.0K
Other Receivables $100.0K $0.00
Total Short-Term Assets $24.29M $7.800M
YoY Change 211.47% 23.81%
LONG-TERM ASSETS
Property, Plant & Equipment $6.769M $5.100M
YoY Change 32.72% -7.27%
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments $13.10M
YoY Change
Other Assets
YoY Change
Total Long-Term Assets $19.95M $5.300M
YoY Change 276.45% -8.62%
TOTAL ASSETS
Total Short-Term Assets $24.29M $7.800M
Total Long-Term Assets $19.95M $5.300M
Total Assets $44.25M $13.10M
YoY Change 237.76% 8.26%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $3.062M $3.600M
YoY Change -14.95% -16.28%
Accrued Expenses $3.388M $3.900M
YoY Change -13.13% 116.67%
Deferred Revenue
YoY Change
Short-Term Debt $0.00 $4.100M
YoY Change -100.0% -22.64%
Long-Term Debt Due $20.16M
YoY Change
Total Short-Term Liabilities $39.29M $22.70M
YoY Change 73.09% 89.17%
LONG-TERM LIABILITIES
Long-Term Debt $7.430M $8.400M
YoY Change -11.55% 394.12%
Other Long-Term Liabilities
YoY Change
Total Long-Term Liabilities $7.430M $8.400M
YoY Change -11.55% 394.12%
TOTAL LIABILITIES
Total Short-Term Liabilities $39.29M $22.70M
Total Long-Term Liabilities $7.430M $8.400M
Total Liabilities $46.72M $31.10M
YoY Change 50.23% 127.01%
SHAREHOLDERS EQUITY
Retained Earnings -$174.0M
YoY Change
Common Stock $69.49K
YoY Change
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity -$22.00M -$18.00M
YoY Change
Total Liabilities & Shareholders Equity $44.25M $13.10M
YoY Change 237.76% 8.26%

Cashflow Statement

Concept 2020 Q1 2019 Q1
OPERATING ACTIVITIES
Net Income $4.757M -$6.264M
YoY Change -175.93% -2.43%
Depreciation, Depletion And Amortization $171.8K $96.69K
YoY Change 77.65% 93.37%
Cash From Operating Activities -$7.823M -$5.769M
YoY Change 35.61% 25.95%
INVESTING ACTIVITIES
Capital Expenditures $464.0K $0.00
YoY Change
Acquisitions
YoY Change
Other Investing Activities
YoY Change
Cash From Investing Activities -$464.0K $0.00
YoY Change
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities $243.0K $7.104M
YoY Change -96.58% 459.36%
NET CHANGE
Cash From Operating Activities -$7.823M -$5.769M
Cash From Investing Activities -$464.0K $0.00
Cash From Financing Activities $243.0K $7.104M
Net Change In Cash -$8.044M $1.335M
YoY Change -702.45% -140.34%
FREE CASH FLOW
Cash From Operating Activities -$7.823M -$5.769M
Capital Expenditures $464.0K $0.00
Free Cash Flow -$8.287M -$5.769M
YoY Change 43.65% 25.95%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2020Q1 dei Entity Central Index Key
EntityCentralIndexKey
0001425287
CY2020Q1 dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2020
CY2020Q1 dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
Q1
CY2020Q1 dei Amendment Flag
AmendmentFlag
false
CY2020Q1 dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--12-31
CY2020Q1 dei Document Type
DocumentType
10-Q
CY2020Q1 dei Document Quarterly Report
DocumentQuarterlyReport
true
CY2020Q1 dei Document Period End Date
DocumentPeriodEndDate
2020-03-31
CY2020Q1 dei Document Transition Report
DocumentTransitionReport
false
CY2020Q1 dei Entity File Number
EntityFileNumber
000-53704
CY2020Q1 dei Entity Registrant Name
EntityRegistrantName
WORKHORSE GROUP INC.
CY2020Q1 dei Entity Incorporation State Country Code
EntityIncorporationStateCountryCode
NV
CY2020Q1 dei Entity Tax Identification Number
EntityTaxIdentificationNumber
26-1394771
CY2020Q1 dei Entity Address Postal Zip Code
EntityAddressPostalZipCode
45140
CY2020Q1 dei Entity Address Address Line1
EntityAddressAddressLine1
100 Commerce Drive
CY2020Q1 dei Entity Address City Or Town
EntityAddressCityOrTown
Loveland
CY2020Q1 dei Entity Address State Or Province
EntityAddressStateOrProvince
OH
CY2020Q1 dei City Area Code
CityAreaCode
513
CY2020Q1 dei Local Phone Number
LocalPhoneNumber
360-4704
CY2020Q1 dei Entity Current Reporting Status
EntityCurrentReportingStatus
Yes
CY2020Q1 dei Entity Interactive Data Current
EntityInteractiveDataCurrent
Yes
CY2020Q1 dei Entity Filer Category
EntityFilerCategory
Accelerated Filer
CY2020Q1 dei Entity Small Business
EntitySmallBusiness
true
CY2020Q1 dei Entity Emerging Growth Company
EntityEmergingGrowthCompany
false
CY2020Q1 dei Entity Shell Company
EntityShellCompany
false
CY2020Q1 dei Security12b Title
Security12bTitle
Common Stock, $0.001 par value per share
CY2020Q1 dei Trading Symbol
TradingSymbol
WKHS
CY2020Q2 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
70629331 shares
CY2020Q1 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
16824627 USD
CY2019Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
23868416 USD
CY2020Q1 us-gaap Restricted Cash
RestrictedCash
0 USD
CY2019Q4 us-gaap Restricted Cash
RestrictedCash
1000000 USD
CY2020Q1 us-gaap Allowance For Doubtful Accounts Receivable Current
AllowanceForDoubtfulAccountsReceivableCurrent
0 USD
CY2019Q4 us-gaap Allowance For Doubtful Accounts Receivable Current
AllowanceForDoubtfulAccountsReceivableCurrent
0 USD
CY2020Q1 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
48830 USD
CY2019Q4 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
7921 USD
CY2020Q1 wkhs Finance Lease Receivable Current
FinanceLeaseReceivableCurrent
33100 USD
CY2019Q4 wkhs Finance Lease Receivable Current
FinanceLeaseReceivableCurrent
33100 USD
CY2020Q1 us-gaap Inventory Net
InventoryNet
2630824 USD
CY2019Q4 us-gaap Inventory Net
InventoryNet
1798146 USD
CY2020Q1 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
4756923 USD
CY2019Q4 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
4812088 USD
CY2020Q1 us-gaap Assets Current
AssetsCurrent
24294304 USD
CY2019Q4 us-gaap Assets Current
AssetsCurrent
31519671 USD
CY2020Q1 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
6768619 USD
CY2019Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
6830181 USD
CY2020Q1 us-gaap Investments And Other Noncurrent Assets
InvestmentsAndOtherNoncurrentAssets
13059700 USD
CY2019Q4 us-gaap Investments And Other Noncurrent Assets
InvestmentsAndOtherNoncurrentAssets
12194800 USD
CY2020Q1 wkhs Finance Lease Receivable Noncurrent
FinanceLeaseReceivableNoncurrent
123661 USD
CY2019Q4 wkhs Finance Lease Receivable Noncurrent
FinanceLeaseReceivableNoncurrent
129177 USD
CY2020Q1 us-gaap Assets
Assets
44246284 USD
CY2019Q4 us-gaap Assets
Assets
50673829 USD
CY2020Q1 us-gaap Accounts Payable Current
AccountsPayableCurrent
3061730 USD
CY2019Q4 us-gaap Accounts Payable Current
AccountsPayableCurrent
1678983 USD
CY2020Q1 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
3387921 USD
CY2019Q4 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
3105184 USD
CY2020Q1 wkhs Warranty Liability
WarrantyLiability
5302770 USD
CY2019Q4 wkhs Warranty Liability
WarrantyLiability
6001864 USD
CY2020Q1 wkhs Fair Value Liability For Warrant
FairValueLiabilityForWarrant
7190000 USD
CY2019Q4 wkhs Fair Value Liability For Warrant
FairValueLiabilityForWarrant
16335000 USD
CY2020Q1 wkhs Customer Deposit Current
CustomerDepositCurrent
190000 USD
CY2019Q4 wkhs Customer Deposit Current
CustomerDepositCurrent
303000 USD
CY2020Q1 us-gaap Long Term Debt Current
LongTermDebtCurrent
20160000 USD
CY2019Q4 us-gaap Long Term Debt Current
LongTermDebtCurrent
19620000 USD
CY2020Q1 us-gaap Liabilities Current
LiabilitiesCurrent
39292421 USD
CY2019Q4 us-gaap Liabilities Current
LiabilitiesCurrent
47044031 USD
CY2020Q1 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.06
CY2020Q1 us-gaap Long Term Debt Noncurrent
LongTermDebtNoncurrent
7430000 USD
CY2019Q4 us-gaap Long Term Debt Noncurrent
LongTermDebtNoncurrent
19400000 USD
CY2020Q1 us-gaap Shares Subject To Mandatory Redemption Settlement Terms Amount Noncurrent
SharesSubjectToMandatoryRedemptionSettlementTermsAmountNoncurrent
19520491 USD
CY2019Q4 us-gaap Shares Subject To Mandatory Redemption Settlement Terms Amount Noncurrent
SharesSubjectToMandatoryRedemptionSettlementTermsAmountNoncurrent
19142908 USD
CY2020Q1 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
USD
CY2019Q4 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
USD
CY2020Q1 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.001
CY2019Q4 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.001
CY2019Q4 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
75000000 shares
CY2020Q1 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
75000000 shares
CY2020Q1 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0 shares
CY2019Q4 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0 shares
CY2019Q4 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0 shares
CY2020Q1 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0 shares
CY2020Q1 us-gaap Preferred Stock Value
PreferredStockValue
0 USD
CY2019Q4 us-gaap Preferred Stock Value
PreferredStockValue
0 USD
CY2020Q1 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.001
CY2019Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.001
CY2019Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
250000000 shares
CY2020Q1 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
250000000 shares
CY2019Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
67105000 shares
CY2019Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
67105000 shares
CY2020Q1 us-gaap Common Stock Value
CommonStockValue
69494 USD
CY2019Q4 us-gaap Common Stock Value
CommonStockValue
67105 USD
CY2020Q1 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
150883717 USD
CY2019Q4 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
143826315 USD
CY2020Q1 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-174049839 USD
CY2019Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-178806530 USD
CY2020Q1 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
1100000 USD
CY2019Q4 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
0 USD
CY2020Q1 us-gaap Stockholders Equity
StockholdersEquity
-21996628 USD
CY2019Q4 us-gaap Stockholders Equity
StockholdersEquity
-34913110 USD
CY2020Q1 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
44246284 USD
CY2019Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
50673829 USD
CY2020Q1 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
84300 USD
CY2019Q1 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
364182 USD
CY2020Q1 us-gaap Cost Of Revenue
CostOfRevenue
1747975 USD
CY2019Q1 us-gaap Cost Of Revenue
CostOfRevenue
1397606 USD
CY2020Q1 us-gaap Gross Profit
GrossProfit
-1663675 USD
CY2019Q1 us-gaap Gross Profit
GrossProfit
-1033424 USD
CY2020Q1 us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
5565787 USD
CY2019Q1 us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
2090890 USD
CY2020Q1 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
1902236 USD
CY2019Q1 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
1362275 USD
CY2020Q1 us-gaap Operating Expenses
OperatingExpenses
7468023 USD
CY2019Q1 us-gaap Operating Expenses
OperatingExpenses
3453165 USD
CY2020Q1 us-gaap Other Operating Income Expense Net
OtherOperatingIncomeExpenseNet
864900 USD
CY2019Q1 us-gaap Other Operating Income Expense Net
OtherOperatingIncomeExpenseNet
0 USD
CY2020Q1 us-gaap Operating Income Loss
OperatingIncomeLoss
-8266798 USD
CY2019Q1 us-gaap Operating Income Loss
OperatingIncomeLoss
-4486589 USD
CY2020Q1 us-gaap Interest Income Other
InterestIncomeOther
13023489 USD
CY2019Q1 us-gaap Interest Expense
InterestExpense
1777583 USD
CY2020Q1 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
4756691 USD
CY2019Q1 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-6264172 USD
CY2020Q1 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
0 USD
CY2019Q1 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
0 USD
CY2020Q1 us-gaap Net Income Loss
NetIncomeLoss
4756691 USD
CY2019Q1 us-gaap Net Income Loss
NetIncomeLoss
-6264172 USD
CY2020Q1 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.07
CY2019Q1 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.11
CY2019Q1 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.11
CY2020Q1 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
68465759 shares
CY2019Q1 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
55260519 shares
CY2020Q1 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
83768820 shares
CY2019Q1 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
55260519 shares
CY2020Q1 us-gaap Net Income Loss
NetIncomeLoss
4756691 USD
CY2019Q1 us-gaap Net Income Loss
NetIncomeLoss
-6264172 USD
CY2020Q1 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
5856691 USD
CY2019Q1 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-6264172 USD
CY2018Q4 us-gaap Stockholders Equity
StockholdersEquity
-15422443 USD
CY2019Q1 us-gaap Stock Issued During Period Value New Issues
StockIssuedDuringPeriodValueNewIssues
2999735 USD
CY2019Q1 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
691070 USD
CY2019Q1 us-gaap Net Income Loss
NetIncomeLoss
-6264172 USD
CY2019Q1 us-gaap Stockholders Equity
StockholdersEquity
-17995810 USD
CY2019Q4 us-gaap Stockholders Equity
StockholdersEquity
-34913110 USD
CY2020Q1 us-gaap Stock Issued During Period Value New Issues
StockIssuedDuringPeriodValueNewIssues
243000 USD
CY2020Q1 wkhs Common Stock Issued For Payment Of Series B Preferred Stock Dividend Amount
CommonStockIssuedForPaymentOfSeriesBPreferredStockDividendAmount
500000 USD
CY2020Q1 us-gaap Stock Issued During Period Value Conversion Of Convertible Securities
StockIssuedDuringPeriodValueConversionOfConvertibleSecurities
5193552 USD
CY2020Q1 wkhs Common Stock Dividends Common Stock Issued For Interest Payments On Convertible Notes Value
CommonStockDividendsCommonStockIssuedForInterestPaymentsOnConvertibleNotesValue
264212 USD
CY2020Q1 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
859027 USD
CY2020Q1 us-gaap Net Income Loss
NetIncomeLoss
4756691 USD
CY2020Q1 us-gaap Other Comprehensive Income Other Net Of Tax
OtherComprehensiveIncomeOtherNetOfTax
1100000 USD
CY2020Q1 us-gaap Stockholders Equity
StockholdersEquity
-21996628 USD
CY2020Q1 us-gaap Net Income Loss
NetIncomeLoss
4756691 USD
CY2019Q1 us-gaap Net Income Loss
NetIncomeLoss
-6264172 USD
CY2020Q1 us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
171761 USD
CY2019Q1 us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
96687 USD
CY2020Q1 wkhs Tooling Expense
ToolingExpense
353786 USD
CY2019Q1 wkhs Tooling Expense
ToolingExpense
0 USD
CY2020Q1 us-gaap Amortization Of Financing Costs
AmortizationOfFinancingCosts
0 USD
CY2019Q1 us-gaap Amortization Of Financing Costs
AmortizationOfFinancingCosts
129050 USD
CY2020Q1 wkhs Amortization Of Discount On Series Preferred Stock
AmortizationOfDiscountOnSeriesPreferredStock
377583 USD
CY2019Q1 wkhs Amortization Of Discount On Series Preferred Stock
AmortizationOfDiscountOnSeriesPreferredStock
0 USD
CY2020Q1 us-gaap Accretion Amortization Of Discounts And Premiums Investments
AccretionAmortizationOfDiscountsAndPremiumsInvestments
400000 USD
CY2020Q1 wkhs Change In Fair Value Convertible Notes
ChangeInFairValueConvertibleNotes
5136448 USD
CY2019Q1 wkhs Change In Fair Value Convertible Notes
ChangeInFairValueConvertibleNotes
0 USD
CY2020Q1 us-gaap Fair Value Adjustment Of Warrants
FairValueAdjustmentOfWarrants
-9145000 USD
CY2019Q1 us-gaap Fair Value Adjustment Of Warrants
FairValueAdjustmentOfWarrants
568066 USD
CY2020Q1 us-gaap Unrealized Gain Loss On Investments
UnrealizedGainLossOnInvestments
864900 USD
CY2019Q1 us-gaap Unrealized Gain Loss On Investments
UnrealizedGainLossOnInvestments
0 USD
CY2020Q1 wkhs Payments For Preferred Stock Dividends Noncash
PaymentsForPreferredStockDividendsNoncash
-500000 USD
CY2019Q1 wkhs Payments For Preferred Stock Dividends Noncash
PaymentsForPreferredStockDividendsNoncash
0 USD
CY2020Q1 wkhs Interest On Convertible Note Paid In Common Stock
InterestOnConvertibleNotePaidInCommonStock
264212 USD
CY2019Q1 wkhs Interest On Convertible Note Paid In Common Stock
InterestOnConvertibleNotePaidInCommonStock
0 USD
CY2020Q1 us-gaap Share Based Compensation
ShareBasedCompensation
859027 USD
CY2019Q1 us-gaap Share Based Compensation
ShareBasedCompensation
691070 USD
CY2020Q1 us-gaap Increase Decrease In Accounts And Other Receivables
IncreaseDecreaseInAccountsAndOtherReceivables
35393 USD
CY2019Q1 us-gaap Increase Decrease In Accounts And Other Receivables
IncreaseDecreaseInAccountsAndOtherReceivables
351138 USD
CY2020Q1 wkhs Increase Decreasein Inventory
IncreaseDecreaseinInventory
832678 USD
CY2019Q1 wkhs Increase Decreasein Inventory
IncreaseDecreaseinInventory
-42818 USD
CY2020Q1 wkhs Increase Decrease In Prepaid Deferred Expenses And Other Assets1
IncreaseDecreaseInPrepaidDeferredExpensesAndOtherAssets1
-55165 USD
CY2019Q1 wkhs Increase Decrease In Prepaid Deferred Expenses And Other Assets1
IncreaseDecreaseInPrepaidDeferredExpensesAndOtherAssets1
-225761 USD
CY2020Q1 wkhs Increase Decrease In Accounts Payable And Accrued Liabilities1
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities1
1665484 USD
CY2019Q1 wkhs Increase Decrease In Accounts Payable And Accrued Liabilities1
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities1
-747229 USD
CY2020Q1 wkhs Increase Decrease In Warranty
IncreaseDecreaseInWarranty
699094 USD
CY2019Q1 wkhs Increase Decrease In Warranty
IncreaseDecreaseInWarranty
147602 USD
CY2020Q1 us-gaap Increase Decrease In Contract With Customer Liability
IncreaseDecreaseInContractWithCustomerLiability
-113000 USD
CY2019Q1 us-gaap Increase Decrease In Contract With Customer Liability
IncreaseDecreaseInContractWithCustomerLiability
-12000 USD
CY2020Q1 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-7822804 USD
CY2019Q1 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-5768689 USD
CY2020Q1 us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
463985 USD
CY2019Q1 us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
0 USD
CY2020Q1 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-463985 USD
CY2019Q1 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
0 USD
CY2020Q1 us-gaap Proceeds From Issuance Of Other Long Term Debt
ProceedsFromIssuanceOfOtherLongTermDebt
0 USD
CY2019Q1 us-gaap Proceeds From Issuance Of Other Long Term Debt
ProceedsFromIssuanceOfOtherLongTermDebt
4104140 USD
CY2020Q1 us-gaap Proceeds From Issuance Or Sale Of Equity
ProceedsFromIssuanceOrSaleOfEquity
0 USD
CY2019Q1 us-gaap Proceeds From Issuance Or Sale Of Equity
ProceedsFromIssuanceOrSaleOfEquity
2999735 USD
CY2020Q1 wkhs Exercise Of Warrants And Options
ExerciseOfWarrantsAndOptions
243000 USD
CY2019Q1 wkhs Exercise Of Warrants And Options
ExerciseOfWarrantsAndOptions
0 USD
CY2020Q1 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
243000 USD
CY2019Q1 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
7103875 USD
CY2020Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
-8043789 USD
CY2019Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
1335186 USD
CY2019Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
24868416 USD
CY2018Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
1512750 USD
CY2020Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
16824627 USD
CY2019Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
2847936 USD
CY2020Q1 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
16824627 USD
CY2019Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
23868416 USD
CY2020Q1 us-gaap Restricted Cash And Cash Equivalents
RestrictedCashAndCashEquivalents
0 USD
CY2019Q4 us-gaap Restricted Cash And Cash Equivalents
RestrictedCashAndCashEquivalents
1000000 USD
CY2020Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
16824627 USD
CY2019Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
24868416 USD
CY2020Q1 us-gaap Debt Conversion Converted Instrument Amount1
DebtConversionConvertedInstrumentAmount1
4335557 USD
CY2020Q1 us-gaap Inventory Raw Materials
InventoryRawMaterials
4489572 USD
CY2019Q4 us-gaap Inventory Raw Materials
InventoryRawMaterials
3741097 USD
CY2020Q1 us-gaap Inventory Work In Process
InventoryWorkInProcess
422176 USD
CY2019Q4 us-gaap Inventory Work In Process
InventoryWorkInProcess
422176 USD
CY2020Q1 us-gaap Inventory Finished Goods
InventoryFinishedGoods
0 USD
CY2019Q4 us-gaap Inventory Finished Goods
InventoryFinishedGoods
0 USD
CY2020Q1 us-gaap Inventory Gross
InventoryGross
4911748 USD
CY2019Q4 us-gaap Inventory Gross
InventoryGross
4163273 USD
CY2020Q1 us-gaap Inventory Valuation Reserves
InventoryValuationReserves
2280924 USD
CY2019Q4 us-gaap Inventory Valuation Reserves
InventoryValuationReserves
2365127 USD
CY2020Q1 us-gaap Inventory Net
InventoryNet
2630824 USD
CY2019Q4 us-gaap Inventory Net
InventoryNet
1798146 USD
CY2020Q1 wkhs Anti Dilution Feature Additional Shares Received Value
AntiDilutionFeatureAdditionalSharesReceivedValue
900000 USD
CY2020Q1 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
84300 USD
CY2019Q1 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
364182 USD
CY2020Q1 us-gaap Long Term Debt Noncurrent
LongTermDebtNoncurrent
7430000 USD
CY2019Q4 us-gaap Long Term Debt Noncurrent
LongTermDebtNoncurrent
19400000 USD
CY2020Q1 wkhs Class Of Warrant Or Right Additional Warrant Issuance Percentage Of Additional Equity Issuances
ClassOfWarrantOrRightAdditionalWarrantIssuancePercentageOfAdditionalEquityIssuances
0.10
CY2020Q1 us-gaap Warrants And Rights Outstanding Term
WarrantsAndRightsOutstandingTerm
P5Y
CY2020Q1 wkhs Class Of Warrant Or Right Exercise Price Of Warrants Or Rights Percentage Of Issuance Price
ClassOfWarrantOrRightExercisePriceOfWarrantsOrRightsPercentageOfIssuancePrice
1.10
CY2020Q1 wkhs Warrant Liability
WarrantLiability
7200000 USD
CY2019Q4 wkhs Warrant Liability
WarrantLiability
16300000 USD
CY2019Q2 us-gaap Warrants And Rights Outstanding Term
WarrantsAndRightsOutstandingTerm
P7Y
CY2020Q1 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
859027 USD
CY2019Q1 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
691070 USD
CY2020Q1 us-gaap Net Income Loss
NetIncomeLoss
4756691 USD
CY2019Q1 us-gaap Net Income Loss
NetIncomeLoss
-6264172 USD
CY2020Q1 us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
4756691 USD
CY2019Q1 us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
-6264172 USD
CY2020Q1 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
68465759 shares
CY2019Q1 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
55260519 shares
CY2020Q1 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
83768820 shares
CY2019Q1 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
55260519 shares
CY2020Q1 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
5066931 shares
CY2019Q1 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
22752782 shares

Files In Submission

Name View Source Status
0001628280-20-006544-index-headers.html Edgar Link pending
0001628280-20-006544-index.html Edgar Link pending
0001628280-20-006544.txt Edgar Link pending
0001628280-20-006544-xbrl.zip Edgar Link pending
FilingSummary.xml Edgar Link unprocessable
Financial_Report.xlsx Edgar Link pending
MetaLinks.json Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
R40.htm Edgar Link pending
R41.htm Edgar Link pending
R42.htm Edgar Link pending
R43.htm Edgar Link pending
R44.htm Edgar Link pending
R45.htm Edgar Link pending
R46.htm Edgar Link pending
R5.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
R9999.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending
wkhs-20200331.htm Edgar Link pending
wkhs-20200331.xsd Edgar Link pending
wkhs-20200331xexx311.htm Edgar Link pending
wkhs-20200331xexx312.htm Edgar Link pending
wkhs-20200331xexx321.htm Edgar Link pending
wkhs-20200331xexx322.htm Edgar Link pending
wkhs-20200331_cal.xml Edgar Link unprocessable
wkhs-20200331_def.xml Edgar Link unprocessable
wkhs-20200331_htm.xml Edgar Link completed
wkhs-20200331_lab.xml Edgar Link unprocessable
wkhs-20200331_pre.xml Edgar Link unprocessable